| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal protein binding | TAOK2 NEFH MYH1 CACNB2 MYH10 MYH13 STUB1 MYH7B FES RAB11FIP5 AFDN FHOD3 HOOK2 JAKMIP3 PLEC DBN1 ARHGEF2 BRSK1 CROCC CCDC88B | 1.30e-08 | 1099 | 82 | 20 | GO:0008092 |
| GeneOntologyMolecularFunction | actin filament binding | 3.86e-07 | 227 | 82 | 9 | GO:0051015 | |
| GeneOntologyMolecularFunction | microfilament motor activity | 1.75e-05 | 38 | 82 | 4 | GO:0000146 | |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 2.35e-05 | 14 | 82 | 3 | GO:0008331 | |
| GeneOntologyMolecularFunction | actin binding | 2.62e-05 | 479 | 82 | 10 | GO:0003779 | |
| GeneOntologyMolecularFunction | low voltage-gated calcium channel activity | 4.98e-05 | 3 | 82 | 2 | GO:0008332 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in AV node cell action potential | 4.98e-05 | 3 | 82 | 2 | GO:0086056 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in cardiac muscle cell action potential | 1.65e-04 | 5 | 82 | 2 | GO:0086007 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 2.03e-04 | 28 | 82 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | small GTPase binding | 3.52e-04 | 321 | 82 | 7 | GO:0031267 | |
| GeneOntologyMolecularFunction | tubulin binding | 3.72e-04 | 428 | 82 | 8 | GO:0015631 | |
| GeneOntologyMolecularFunction | GTPase binding | 6.97e-04 | 360 | 82 | 7 | GO:0051020 | |
| GeneOntologyMolecularFunction | tau protein binding | 8.92e-04 | 46 | 82 | 3 | GO:0048156 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 8.92e-04 | 46 | 82 | 3 | GO:0005245 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.42e-03 | 118 | 82 | 4 | GO:0003774 | |
| GeneOntologyMolecularFunction | microtubule binding | 1.68e-03 | 308 | 82 | 6 | GO:0008017 | |
| GeneOntologyMolecularFunction | calcium channel activity | 1.97e-03 | 129 | 82 | 4 | GO:0005262 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 2.63e-03 | 231 | 82 | 5 | GO:0005085 | |
| GeneOntologyMolecularFunction | cadherin binding | 2.72e-03 | 339 | 82 | 6 | GO:0045296 | |
| GeneOntologyBiologicalProcess | actin filament-based movement | 2.37e-06 | 153 | 81 | 7 | GO:0030048 | |
| GeneOntologyBiologicalProcess | microtubule-based process | BICDL2 FSIP2 NEFH PHLDB1 RSPH3 AKAP9 CFAP73 FES NINL HOOK2 ARHGEF2 BRSK1 BSN CROCC CCDC88B ODAD3 | 2.96e-06 | 1058 | 81 | 16 | GO:0007017 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | FSIP2 NEFH PHLDB1 AKAP9 CFAP73 FES NINL HOOK2 ARHGEF2 BRSK1 CROCC CCDC88B ODAD3 | 4.32e-06 | 720 | 81 | 13 | GO:0000226 |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 1.08e-05 | 127 | 81 | 6 | GO:0070252 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | NEFH MYH10 TCHH AKAP9 PSEN1 KCTD13 FES FHOD3 HOOK2 PLEC DBN1 ARHGEF2 CCDC88B ARF6 | 1.95e-05 | 957 | 81 | 14 | GO:0097435 |
| GeneOntologyBiologicalProcess | postsynapse organization | 3.16e-05 | 313 | 81 | 8 | GO:0099173 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 3.27e-05 | 93 | 81 | 5 | GO:0086003 | |
| GeneOntologyBiologicalProcess | actin filament-based process | TAOK2 CACNB2 MYH10 AKAP9 KCTD13 MYH7B FHOD3 CACNA1H CACNA1G PLEC DBN1 ARHGEF2 ARF6 | 5.23e-05 | 912 | 81 | 13 | GO:0030029 |
| GeneOntologyBiologicalProcess | regulation of actin filament-based movement | 5.58e-05 | 53 | 81 | 4 | GO:1903115 | |
| GeneOntologyBiologicalProcess | muscle contraction | 1.75e-04 | 400 | 81 | 8 | GO:0006936 | |
| GeneOntologyBiologicalProcess | membrane depolarization during AV node cell action potential | 2.26e-04 | 6 | 81 | 2 | GO:0086045 | |
| GeneOntologyCellularComponent | myosin filament | 2.61e-06 | 25 | 82 | 4 | GO:0032982 | |
| GeneOntologyCellularComponent | myosin II complex | 4.19e-06 | 28 | 82 | 4 | GO:0016460 | |
| GeneOntologyCellularComponent | postsynapse | TAOK2 NEFH MYH10 AKAP9 PSEN1 GPR50 LZTS1 AFDN CACNA1H PLCB3 DBN1 CTNND1 ARHGEF2 BSN ARF6 | 8.62e-06 | 1018 | 82 | 15 | GO:0098794 |
| GeneOntologyCellularComponent | dendrite | TAOK2 NEFH MYH10 AKAP9 PSEN1 LZTS1 CACNA1H CACNA1G PLEC DBN1 CTNND1 ARHGEF2 BSN | 2.78e-05 | 858 | 82 | 13 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | TAOK2 NEFH MYH10 AKAP9 PSEN1 LZTS1 CACNA1H CACNA1G PLEC DBN1 CTNND1 ARHGEF2 BSN | 2.85e-05 | 860 | 82 | 13 | GO:0097447 |
| GeneOntologyCellularComponent | ciliary rootlet | 3.14e-05 | 16 | 82 | 3 | GO:0035253 | |
| GeneOntologyCellularComponent | subapical part of cell | 4.55e-05 | 3 | 82 | 2 | GO:0120219 | |
| GeneOntologyCellularComponent | postsynaptic density | 6.80e-05 | 451 | 82 | 9 | GO:0014069 | |
| GeneOntologyCellularComponent | glutamatergic synapse | TAOK2 MLF2 MYH10 AKAP9 PSEN1 LZTS1 CACNA1H DBN1 CTNND1 ARHGEF2 BSN ARF6 | 7.85e-05 | 817 | 82 | 12 | GO:0098978 |
| GeneOntologyCellularComponent | myosin complex | 8.49e-05 | 59 | 82 | 4 | GO:0016459 | |
| GeneOntologyCellularComponent | cell cortex | 1.04e-04 | 371 | 82 | 8 | GO:0005938 | |
| GeneOntologyCellularComponent | asymmetric synapse | 1.04e-04 | 477 | 82 | 9 | GO:0032279 | |
| GeneOntologyCellularComponent | postsynaptic cytoskeleton | 1.42e-04 | 26 | 82 | 3 | GO:0099571 | |
| GeneOntologyCellularComponent | postsynaptic specialization | 1.55e-04 | 503 | 82 | 9 | GO:0099572 | |
| GeneOntologyCellularComponent | dendritic shaft | 2.05e-04 | 74 | 82 | 4 | GO:0043198 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 2.08e-04 | 523 | 82 | 9 | GO:0098984 | |
| GeneOntologyCellularComponent | presynaptic active zone | 2.34e-04 | 141 | 82 | 5 | GO:0048786 | |
| GeneOntologyCellularComponent | microtubule organizing center | MFAP1 AKAP9 PSEN1 CEP95 NINL RAB11FIP5 HOOK2 RILP BRSK1 CROCC CCDC88B ODAD3 | 2.36e-04 | 919 | 82 | 12 | GO:0005815 |
| GeneOntologyCellularComponent | somatodendritic compartment | TAOK2 NEFH MYH10 AKAP9 PSEN1 LZTS1 AFDN CACNA1H CACNA1G PLEC DBN1 CTNND1 ARHGEF2 BSN | 2.78e-04 | 1228 | 82 | 14 | GO:0036477 |
| GeneOntologyCellularComponent | actin cytoskeleton | 4.22e-04 | 576 | 82 | 9 | GO:0015629 | |
| GeneOntologyCellularComponent | supramolecular fiber | NEFH MYH1 MFAP1 MYH10 MYH13 STUB1 MYH7B NINL FHOD3 HOOK2 PLEC DBN1 ARHGEF2 | 6.46e-04 | 1179 | 82 | 13 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | NEFH MYH1 MFAP1 MYH10 MYH13 STUB1 MYH7B NINL FHOD3 HOOK2 PLEC DBN1 ARHGEF2 | 6.88e-04 | 1187 | 82 | 13 | GO:0099081 |
| GeneOntologyCellularComponent | myofibril | 7.17e-04 | 273 | 82 | 6 | GO:0030016 | |
| GeneOntologyCellularComponent | cell cortex region | 7.33e-04 | 45 | 82 | 3 | GO:0099738 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 7.82e-04 | 46 | 82 | 3 | GO:0005891 | |
| GeneOntologyCellularComponent | centrosome | MFAP1 AKAP9 PSEN1 CEP95 NINL RAB11FIP5 HOOK2 BRSK1 CROCC CCDC88B | 8.46e-04 | 770 | 82 | 10 | GO:0005813 |
| GeneOntologyCellularComponent | sarcolemma | 9.12e-04 | 190 | 82 | 5 | GO:0042383 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 9.81e-04 | 290 | 82 | 6 | GO:0043292 | |
| GeneOntologyCellularComponent | filopodium | 1.40e-03 | 123 | 82 | 4 | GO:0030175 | |
| GeneOntologyCellularComponent | muscle myosin complex | 1.76e-03 | 16 | 82 | 2 | GO:0005859 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 1.99e-03 | 17 | 82 | 2 | GO:0001518 | |
| GeneOntologyCellularComponent | extrinsic component of membrane | 2.12e-03 | 230 | 82 | 5 | GO:0019898 | |
| GeneOntologyCellularComponent | hippocampal mossy fiber to CA3 synapse | 2.33e-03 | 67 | 82 | 3 | GO:0098686 | |
| GeneOntologyCellularComponent | postsynaptic actin cytoskeleton | 2.49e-03 | 19 | 82 | 2 | GO:0098871 | |
| GeneOntologyCellularComponent | axon | 2.50e-03 | 891 | 82 | 10 | GO:0030424 | |
| GeneOntologyCellularComponent | growth cone | 2.78e-03 | 245 | 82 | 5 | GO:0030426 | |
| GeneOntologyCellularComponent | cytoplasmic region | 2.92e-03 | 360 | 82 | 6 | GO:0099568 | |
| GeneOntologyCellularComponent | calcium channel complex | 2.97e-03 | 73 | 82 | 3 | GO:0034704 | |
| GeneOntologyCellularComponent | site of polarized growth | 3.19e-03 | 253 | 82 | 5 | GO:0030427 | |
| GeneOntologyCellularComponent | cell body | NEFH MYH10 AKAP9 PSEN1 LZTS1 CACNA1H CACNA1G DBN1 ARHGEF2 BSN | 3.38e-03 | 929 | 82 | 10 | GO:0044297 |
| GeneOntologyCellularComponent | presynaptic active zone cytoplasmic component | 3.65e-03 | 23 | 82 | 2 | GO:0098831 | |
| GeneOntologyCellularComponent | inclusion body | 5.35e-03 | 90 | 82 | 3 | GO:0016234 | |
| GeneOntologyCellularComponent | neuronal cell body | 5.37e-03 | 835 | 82 | 9 | GO:0043025 | |
| GeneOntologyCellularComponent | sodium channel complex | 5.76e-03 | 29 | 82 | 2 | GO:0034706 | |
| Domain | Myosin_N | 5.00e-07 | 15 | 84 | 4 | PF02736 | |
| Domain | Myosin_N | 5.00e-07 | 15 | 84 | 4 | IPR004009 | |
| Domain | Myosin_tail_1 | 1.11e-06 | 18 | 84 | 4 | PF01576 | |
| Domain | Myosin_tail | 1.11e-06 | 18 | 84 | 4 | IPR002928 | |
| Domain | Myosin-like_IQ_dom | 1.40e-06 | 19 | 84 | 4 | IPR027401 | |
| Domain | - | 1.40e-06 | 19 | 84 | 4 | 4.10.270.10 | |
| Domain | GOLGA6L | 1.74e-06 | 6 | 84 | 3 | IPR026737 | |
| Domain | DGCR6 | 2.00e-05 | 2 | 84 | 2 | PF07324 | |
| Domain | Gonadal | 2.00e-05 | 2 | 84 | 2 | IPR010849 | |
| Domain | Myosin_head_motor_dom | 2.50e-05 | 38 | 84 | 4 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 2.50e-05 | 38 | 84 | 4 | PS51456 | |
| Domain | Myosin_head | 2.50e-05 | 38 | 84 | 4 | PF00063 | |
| Domain | MYSc | 2.50e-05 | 38 | 84 | 4 | SM00242 | |
| Domain | VDCC_T_a1 | 5.98e-05 | 3 | 84 | 2 | IPR005445 | |
| Domain | GOLGA2L5 | 6.82e-05 | 18 | 84 | 3 | PF15070 | |
| Domain | Golgin_A | 6.82e-05 | 18 | 84 | 3 | IPR024858 | |
| Domain | HOOK | 2.96e-04 | 6 | 84 | 2 | PF05622 | |
| Domain | Hook-related_fam | 2.96e-04 | 6 | 84 | 2 | IPR008636 | |
| Domain | IQ | 4.87e-04 | 81 | 84 | 4 | SM00015 | |
| Domain | PH | 5.83e-04 | 229 | 84 | 6 | PF00169 | |
| Domain | IQ_motif_EF-hand-BS | 7.25e-04 | 90 | 84 | 4 | IPR000048 | |
| Domain | IQ | 8.20e-04 | 93 | 84 | 4 | PS50096 | |
| Domain | VDCCAlpha1 | 8.79e-04 | 10 | 84 | 2 | IPR002077 | |
| Domain | PH | 1.59e-03 | 278 | 84 | 6 | SM00233 | |
| Domain | PH_DOMAIN | 1.62e-03 | 279 | 84 | 6 | PS50003 | |
| Domain | PH_domain | 1.65e-03 | 280 | 84 | 6 | IPR001849 | |
| Domain | EF-hand-dom_pair | 1.86e-03 | 287 | 84 | 6 | IPR011992 | |
| Domain | - | 1.90e-03 | 391 | 84 | 7 | 2.30.29.30 | |
| Domain | PH_dom-like | 3.06e-03 | 426 | 84 | 7 | IPR011993 | |
| Domain | IQ | 4.02e-03 | 71 | 84 | 3 | PF00612 | |
| Domain | P-loop_NTPase | 4.67e-03 | 848 | 84 | 10 | IPR027417 | |
| Domain | - | 6.46e-03 | 261 | 84 | 5 | 1.10.238.10 | |
| Domain | FHA_DOMAIN | 8.54e-03 | 31 | 84 | 2 | PS50006 | |
| Domain | FHA | 8.54e-03 | 31 | 84 | 2 | PF00498 | |
| Pubmed | TAOK2 NEFH CACNB2 MYH10 AKAP9 LZTS1 OSBPL3 SAFB2 AFDN JAKMIP3 DBN1 EDC4 CTNND1 ARHGEF2 BRSK1 BSN CCDC177 EMSY | 2.03e-11 | 963 | 86 | 18 | 28671696 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | FSIP2 PLEKHG1 PHLDB1 AKAP9 CEP95 OSBPL3 BRD4 RAB11FIP5 AFDN SH3BP5L PLEC EDC4 CTNND1 ARHGEF2 | 2.55e-08 | 861 | 86 | 14 | 36931259 |
| Pubmed | NEFH CACNB2 PHLDB1 MYH10 KCTD13 LZTS1 AFDN PLEC DBN1 EDC4 CTNND1 ARHGEF2 BRSK1 BSN CROCC CCDC177 ST13 | 6.83e-08 | 1431 | 86 | 17 | 37142655 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TAOK2 EPN3 PLEKHG1 PHLDB1 TNRC18 ARAP3 BRD4 DEF6 NINL CACNA1H SH3BP5L PLEC EDC4 ARHGEF2 ANO8 | 8.17e-08 | 1105 | 86 | 15 | 35748872 |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | PHLDB1 MYH10 KCTD13 STUB1 GEMIN8 NUCB1 SAFB2 NINL HOOK2 EDC4 CCDC88B | 1.41e-07 | 560 | 86 | 11 | 21653829 |
| Pubmed | 4.36e-07 | 187 | 86 | 7 | 26460568 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | MYCN MFAP1 STUB1 ZC3H13 BRD4 SAFB2 AFDN PLCB3 PLEC DBN1 ARHGEF2 EMSY | 4.60e-07 | 774 | 86 | 12 | 15302935 |
| Pubmed | Biological insights from 108 schizophrenia-associated genetic loci. | 8.91e-07 | 303 | 86 | 8 | 25056061 | |
| Pubmed | 2.44e-06 | 347 | 86 | 8 | 17114649 | ||
| Pubmed | 3.35e-06 | 486 | 86 | 9 | 20936779 | ||
| Pubmed | 3.44e-06 | 255 | 86 | 7 | 15324660 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 14988077 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 21622683 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 20685979 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 24268883 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 22832905 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 21092861 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 22469755 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 15821931 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 23436820 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 21079360 | ||
| Pubmed | CHIP mediates down-regulation of nucleobindin-1 in preosteoblast cell line models. | 6.04e-06 | 2 | 86 | 2 | 27178152 | |
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 31042060 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 22886848 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 24952595 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 11157784 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 9605865 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 29082441 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 22574369 | ||
| Pubmed | Blockade of T-type Ca(2+) channels inhibits human ovarian cancer cell proliferation. | 6.04e-06 | 2 | 86 | 2 | 21438841 | |
| Pubmed | β-Adrenergic stimulation increases Cav3.1 activity in cardiac myocytes through protein kinase A. | 6.04e-06 | 2 | 86 | 2 | 22808078 | |
| Pubmed | 7.86e-06 | 407 | 86 | 8 | 12693553 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | PLEKHG1 MYH10 MGST1 STUB1 CEP95 OSBPL3 NINL AFDN PLEC ARHGEF2 EMSY | 8.31e-06 | 853 | 86 | 11 | 28718761 |
| Pubmed | 1.00e-05 | 54 | 86 | 4 | 22266860 | ||
| Pubmed | Functional specialization of beta-arrestin interactions revealed by proteomic analysis. | 1.42e-05 | 317 | 86 | 7 | 17620599 | |
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 24327205 | ||
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 36515178 | ||
| Pubmed | Ethanol inhibition of a T-type Ca²+ channel through activity of protein kinase C. | 1.81e-05 | 3 | 86 | 2 | 23488970 | |
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 24966091 | ||
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 26488564 | ||
| Pubmed | Differential interactions of Na+ channel toxins with T-type Ca2+ channels. | 1.81e-05 | 3 | 86 | 2 | 18591418 | |
| Pubmed | Identification of the t-type calcium channel (Ca(v)3.1d) in developing mouse heart. | 1.81e-05 | 3 | 86 | 2 | 11230107 | |
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 28846697 | ||
| Pubmed | Caveolin-3 regulates protein kinase A modulation of the Ca(V)3.2 (alpha1H) T-type Ca2+ channels. | 1.81e-05 | 3 | 86 | 2 | 21084288 | |
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 33547341 | ||
| Pubmed | Calmodulin regulates Cav3 T-type channels at their gating brake. | 1.81e-05 | 3 | 86 | 2 | 28972185 | |
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 11927664 | ||
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 25567808 | ||
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 38200184 | ||
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 22572848 | ||
| Pubmed | Drebrin preserves endothelial integrity by stabilizing nectin at adherens junctions. | 1.81e-05 | 3 | 86 | 2 | 23750010 | |
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 22715045 | ||
| Pubmed | Isolation of human delta-catenin and its binding specificity with presenilin 1. | 1.81e-05 | 3 | 86 | 2 | 10208590 | |
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 31919478 | ||
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 25825486 | ||
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 11897840 | ||
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 21732359 | ||
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 37739992 | ||
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 15845543 | ||
| Pubmed | TAOK2 TNRC18 MYH10 KCTD13 AFDN PLEC DBN1 EDC4 CTNND1 BSN ST13 ANO8 | 2.36e-05 | 1139 | 86 | 12 | 36417873 | |
| Pubmed | 3.61e-05 | 4 | 86 | 2 | 31800012 | ||
| Pubmed | 3.61e-05 | 4 | 86 | 2 | 10388558 | ||
| Pubmed | Akt phosphorylation at Thr308 and Ser473 is required for CHIP-mediated ubiquitination of the kinase. | 3.61e-05 | 4 | 86 | 2 | 21767636 | |
| Pubmed | Pharmacogenetics of antiepileptic drug efficacy in childhood absence epilepsy. | 3.61e-05 | 4 | 86 | 2 | 28165634 | |
| Pubmed | 3.61e-05 | 4 | 86 | 2 | 8808291 | ||
| Pubmed | 3.61e-05 | 4 | 86 | 2 | 30573686 | ||
| Pubmed | Functional importance of L- and P/Q-type voltage-gated calcium channels in human renal vasculature. | 3.61e-05 | 4 | 86 | 2 | 21788606 | |
| Pubmed | 3.61e-05 | 4 | 86 | 2 | 28655554 | ||
| Pubmed | 4.42e-05 | 156 | 86 | 5 | 32850835 | ||
| Pubmed | Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. | 5.09e-05 | 29 | 86 | 3 | 21909115 | |
| Pubmed | Integration of cytogenetic with recombinational and physical maps of mouse chromosome 16. | 6.01e-05 | 5 | 86 | 2 | 10395793 | |
| Pubmed | 6.01e-05 | 5 | 86 | 2 | 10421573 | ||
| Pubmed | 6.01e-05 | 5 | 86 | 2 | 25681462 | ||
| Pubmed | 6.01e-05 | 5 | 86 | 2 | 12060068 | ||
| Pubmed | T-type calcium channels functionally interact with spectrin (α/β) and ankyrin B. | 6.01e-05 | 5 | 86 | 2 | 29720258 | |
| Pubmed | 6.24e-05 | 31 | 86 | 3 | 21985497 | ||
| Pubmed | Proteomic analysis of NMDA receptor-adhesion protein signaling complexes. | 6.34e-05 | 86 | 86 | 4 | 10862698 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 7.50e-05 | 283 | 86 | 6 | 30585729 | |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | 7.97e-05 | 564 | 86 | 8 | 21565611 | |
| Pubmed | 9.01e-05 | 6 | 86 | 2 | 26414348 | ||
| Pubmed | Bromodomain Protein BRD4 Is Essential for Hair Cell Function and Survival. | 9.01e-05 | 6 | 86 | 2 | 33015071 | |
| Pubmed | 9.01e-05 | 6 | 86 | 2 | 11226248 | ||
| Pubmed | Hakai, an E3-ligase for E-cadherin, stabilizes δ-catenin through Src kinase. | 9.01e-05 | 6 | 86 | 2 | 28069439 | |
| Pubmed | 9.01e-05 | 6 | 86 | 2 | 11804589 | ||
| Pubmed | Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved. | 9.01e-05 | 6 | 86 | 2 | 10077619 | |
| Pubmed | Regulation of death-associated protein kinase. Stabilization by HSP90 heterocomplexes. | 9.01e-05 | 6 | 86 | 2 | 17324930 | |
| Pubmed | 9.01e-05 | 6 | 86 | 2 | 23990464 | ||
| Pubmed | 1.10e-04 | 591 | 86 | 8 | 15231748 | ||
| Pubmed | 1.14e-04 | 100 | 86 | 4 | 10048485 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | MYH10 KCTD13 MGST1 OSBPL3 SAFB2 RAB11FIP5 PLEC DBN1 ARHGEF2 DDX28 | 1.19e-04 | 949 | 86 | 10 | 36574265 |
| Pubmed | Mouse proteasomal ATPases Psmc3 and Psmc4: genomic organization and gene targeting. | 1.26e-04 | 7 | 86 | 2 | 10945464 | |
| Pubmed | 1.26e-04 | 7 | 86 | 2 | 35210422 | ||
| Pubmed | 1.26e-04 | 7 | 86 | 2 | 12900400 | ||
| Pubmed | Lens placode planar cell polarity is dependent on Cdc42-mediated junctional contraction inhibition. | 1.26e-04 | 7 | 86 | 2 | 26902112 | |
| Pubmed | 1.26e-04 | 7 | 86 | 2 | 19114997 | ||
| Pubmed | A novel hook-related protein family and the characterization of hook-related protein 1. | 1.26e-04 | 7 | 86 | 2 | 15882442 | |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 1.30e-04 | 313 | 86 | 6 | 38270169 | |
| Pubmed | 1.35e-04 | 40 | 86 | 3 | 28386764 | ||
| Pubmed | TAOK2 MFAP1 MYH10 AKAP9 MYH13 MGST1 OSBPL3 PLEC CTNND1 ARHGEF2 DDX28 ARF6 | 1.39e-04 | 1371 | 86 | 12 | 36244648 | |
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | 1.54e-04 | 621 | 86 | 8 | 22794259 | |
| Interaction | YWHAG interactions | TAOK2 LNP1 MYCN PLEKHG1 MFAP1 PHLDB1 MYH10 AKAP9 KCTD13 CEP95 OSBPL3 ZC3H13 NINL RAB11FIP5 AFDN SH3BP5L EDC4 CTNND1 ARHGEF2 ST13 | 1.14e-07 | 1248 | 83 | 20 | int:YWHAG |
| Interaction | YWHAE interactions | TAOK2 EPN3 LNP1 MYCN HDAC9 PHLDB1 MYH10 AKAP9 KCTD13 STUB1 CEP95 OSBPL3 BRD4 RAB11FIP5 AFDN DBN1 CTNND1 ARHGEF2 BRSK1 | 6.10e-07 | 1256 | 83 | 19 | int:YWHAE |
| Interaction | FMR1 interactions | MYCN CACNB2 AKAP9 KCTD13 STUB1 BRD4 SAFB2 EDC4 ARHGEF2 BRSK1 BSN EMSY | 1.93e-06 | 536 | 83 | 12 | int:FMR1 |
| Interaction | YWHAH interactions | LNP1 PLEKHG1 PHLDB1 AKAP9 KCTD13 CEP95 OSBPL3 ZC3H13 BRD4 NINL RAB11FIP5 AFDN SH3BP5L PLEC EDC4 CTNND1 ARHGEF2 | 2.05e-06 | 1102 | 83 | 17 | int:YWHAH |
| Interaction | GRIN1 interactions | 3.39e-06 | 154 | 83 | 7 | int:GRIN1 | |
| Interaction | FXR1 interactions | MYCN MFAP1 PHLDB1 MYH10 AKAP9 KCTD13 STUB1 MYH7B BRD4 SAFB2 AFDN EDC4 ARHGEF2 | 3.88e-06 | 679 | 83 | 13 | int:FXR1 |
| Interaction | YWHAZ interactions | LNP1 MYCN HDAC9 FSIP2 MFAP1 PHLDB1 MYH10 AKAP9 KCTD13 CEP95 OSBPL3 BRD4 RAB11FIP5 AFDN SH3BP5L PLEC CTNND1 ARHGEF2 | 5.48e-06 | 1319 | 83 | 18 | int:YWHAZ |
| Interaction | TOP3B interactions | TAOK2 EPN3 MYCN PLEKHG1 PHLDB1 TNRC18 MYH10 ARAP3 BRD4 DEF6 SAFB2 NINL CACNA1H SH3BP5L PLEC EDC4 ARHGEF2 DDX28 ANO8 | 6.26e-06 | 1470 | 83 | 19 | int:TOP3B |
| Interaction | GAN interactions | 9.67e-06 | 253 | 83 | 8 | int:GAN | |
| Interaction | PLEKHA7 interactions | 9.73e-06 | 119 | 83 | 6 | int:PLEKHA7 | |
| Interaction | ARRB2 interactions | 1.71e-05 | 454 | 83 | 10 | int:ARRB2 | |
| Interaction | ARHGAP21 interactions | 3.76e-05 | 223 | 83 | 7 | int:ARHGAP21 | |
| Interaction | KCTD13 interactions | NEFH CACNB2 PHLDB1 MYH10 KCTD13 LZTS1 AFDN PLEC DBN1 EDC4 CTNND1 ARHGEF2 BRSK1 BSN CROCC CCDC177 ST13 | 4.44e-05 | 1394 | 83 | 17 | int:KCTD13 |
| Interaction | INIP interactions | 4.53e-05 | 48 | 83 | 4 | int:INIP | |
| Interaction | YWHAQ interactions | LNP1 MYCN PHLDB1 MYH13 KCTD13 STUB1 CEP95 OSBPL3 ZC3H13 BRD4 AFDN SH3BP5L PLEC CTNND1 ARHGEF2 | 4.59e-05 | 1118 | 83 | 15 | int:YWHAQ |
| Interaction | PLEKHA5 interactions | 4.70e-05 | 231 | 83 | 7 | int:PLEKHA5 | |
| Interaction | YWHAB interactions | LNP1 MYCN PHLDB1 AKAP9 KCTD13 CEP95 OSBPL3 NINL RAB11FIP5 AFDN SH3BP5L CTNND1 ARHGEF2 ST13 | 6.27e-05 | 1014 | 83 | 14 | int:YWHAB |
| Interaction | BCR interactions | 6.64e-05 | 244 | 83 | 7 | int:BCR | |
| Interaction | HSPB8 interactions | 7.76e-05 | 172 | 83 | 6 | int:HSPB8 | |
| Interaction | BMI1 interactions | MYCN AKAP9 ZC3H13 BRD4 SAFB2 RAB11FIP5 PLEC DBN1 EDC4 CTNND1 ARHGEF2 | 8.00e-05 | 659 | 83 | 11 | int:BMI1 |
| Interaction | INA interactions | 8.02e-05 | 173 | 83 | 6 | int:INA | |
| Interaction | HSPA2 interactions | 8.18e-05 | 440 | 83 | 9 | int:HSPA2 | |
| Interaction | DYRK1A interactions | MFAP1 KCTD13 LZTS1 GEMIN8 NUCB1 SAFB2 NINL RAB11FIP5 DBN1 CTNND1 | 8.86e-05 | 552 | 83 | 10 | int:DYRK1A |
| Interaction | TPM1 interactions | 1.06e-04 | 263 | 83 | 7 | int:TPM1 | |
| Interaction | TNKS2 interactions | 1.17e-04 | 61 | 83 | 4 | int:TNKS2 | |
| Interaction | ABLIM2 interactions | 1.28e-04 | 24 | 83 | 3 | int:ABLIM2 | |
| Interaction | WHAMMP3 interactions | 1.33e-04 | 119 | 83 | 5 | int:WHAMMP3 | |
| Interaction | JUP interactions | 1.71e-04 | 485 | 83 | 9 | int:JUP | |
| Interaction | EFL1 interactions | 1.89e-04 | 69 | 83 | 4 | int:EFL1 | |
| Interaction | CCDC177 interactions | 2.49e-04 | 6 | 83 | 2 | int:CCDC177 | |
| Interaction | CHST13 interactions | 2.49e-04 | 6 | 83 | 2 | int:CHST13 | |
| Interaction | CLEC1B interactions | 2.49e-04 | 6 | 83 | 2 | int:CLEC1B | |
| Interaction | LZTS2 interactions | 2.55e-04 | 512 | 83 | 9 | int:LZTS2 | |
| Cytoband | 15q25.2 | 7.16e-05 | 43 | 85 | 3 | 15q25.2 | |
| Cytoband | 16q22.1 | 1.15e-03 | 110 | 85 | 3 | 16q22.1 | |
| Cytoband | 17p13 | 1.83e-03 | 34 | 85 | 2 | 17p13 | |
| GeneFamily | Myosin heavy chains | 6.91e-08 | 15 | 50 | 4 | 1098 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.13e-05 | 206 | 50 | 6 | 682 | |
| GeneFamily | Calcium voltage-gated channel subunits | 4.95e-05 | 26 | 50 | 3 | 253 | |
| GeneFamily | EF-hand domain containing | 3.12e-03 | 219 | 50 | 4 | 863 | |
| ToppCell | RV|World / Chamber and Cluster_Paper | 1.40e-06 | 181 | 86 | 6 | bbe1e6e59d8889bd37d6e8303116cbdcafca7236 | |
| ToppCell | Endothelial-B-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 1.71e-05 | 165 | 86 | 5 | b6893882472aeb0d18e26f47eaec9d53688afcde | |
| ToppCell | droplet-Spleen-nan-3m-Myeloid-granulocyte|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-05 | 170 | 86 | 5 | dbd6c9c7be824a1ff1b31af791064127cafbd194 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.03e-05 | 171 | 86 | 5 | 2a34685f7d83d1cf9a88d304173cbca868c5f9fd | |
| ToppCell | AT1-AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 2.09e-05 | 172 | 86 | 5 | 0be41df5d35d818deb7316ac21c9366eb4b7bfd1 | |
| ToppCell | LV|World / Chamber and Cluster_Paper | 2.60e-05 | 180 | 86 | 5 | 5ac6f485a58bb29462fec02dfbe8eb70864eafe3 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.67e-05 | 181 | 86 | 5 | e898ecb8d8f2eb2204225b7b0d665cadcd241139 | |
| ToppCell | droplet-Heart-4Chambers-21m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.74e-05 | 182 | 86 | 5 | b1c1bb1b80c65dea2558051fd5953c1c4a251c1e | |
| ToppCell | droplet-Heart-4Chambers-21m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-05 | 183 | 86 | 5 | 29defb21458bc43d22ca5e4d08218db45aaa1add | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.89e-05 | 184 | 86 | 5 | af6522586d012e91241f3e06c60f9d1881e95646 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 2.96e-05 | 185 | 86 | 5 | 857c7ca8493e91ef1d0078ddafd6082020f9b169 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 2.96e-05 | 185 | 86 | 5 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 3.20e-05 | 188 | 86 | 5 | 0758b474457efa36488e0195f7357100f4b6a090 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 3.36e-05 | 190 | 86 | 5 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.62e-05 | 193 | 86 | 5 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | LPS-IL1RA-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.71e-05 | 194 | 86 | 5 | 43f92b0533e26633dc94cce554045d641ef8fd76 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.71e-05 | 194 | 86 | 5 | 1d39d968730a7e85b6161c1c8a6bd38afe9bcad7 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.81e-05 | 195 | 86 | 5 | 12ba6d95e42d06b1991b011043c0e3370a7b4131 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 4.00e-05 | 197 | 86 | 5 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.09e-05 | 198 | 86 | 5 | c12e7511628db819a52959bb68580e27c00c2e41 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.29e-05 | 200 | 86 | 5 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 4.29e-05 | 200 | 86 | 5 | eb94a5111ef0e903ee5be9f7efe571b4e6d5fce1 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.29e-05 | 200 | 86 | 5 | a66449b22b39dd6987fc2c3ed160d24564234ced | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.4.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.29e-05 | 200 | 86 | 5 | 694ebc8cc14f80b6f2f4acec4ce7452d8b816af8 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Ptgdr|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.01e-04 | 125 | 86 | 4 | d05556ea185c15815a4f8643f1c01185badbeece | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 1.48e-04 | 138 | 86 | 4 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | Transverse-Dendritic_cell-cDC2|Dendritic_cell / Region, Cell class and subclass | 1.83e-04 | 57 | 86 | 3 | 8d1ee7e3cfea05418f3a64edc07a76f3cbb1a471 | |
| ToppCell | VE-Treg-naive_CD4|VE / Condition, Cell_class and T cell subcluster | 2.37e-04 | 156 | 86 | 4 | 6501baf73616e702946de9fb13d267e30a68888b | |
| ToppCell | 368C-Myeloid-Dendritic-cDC1|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.67e-04 | 161 | 86 | 4 | 1011094c54381d52566e24c92f89f2efc2aa3eea | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-neuro-epithelial-EECs|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.73e-04 | 162 | 86 | 4 | 478cf560ef33c5c324142c76417447d4a571a2c9 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.80e-04 | 163 | 86 | 4 | 8f24cef152f5965727bbeee116bd26c75cbba82a | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.80e-04 | 163 | 86 | 4 | e4077e587895c85bc806be05ff5d451088e39468 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.86e-04 | 164 | 86 | 4 | 43630a448f4369fa9e4e3eccdf3b9f29cec16c39 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.86e-04 | 164 | 86 | 4 | 108fbecb56d69a675d6ce6e826a873ae528f2fd7 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal--glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.86e-04 | 164 | 86 | 4 | 46208f18325976c89f572f6627aea0582142b92d | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-L_cells_(PYY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.00e-04 | 166 | 86 | 4 | eb9c81fa7573de7aff6670e7dad313f02129809f | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.00e-04 | 166 | 86 | 4 | 66026988509e39e41274fa0de738383219e8ff30 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D175|Adult / Lineage, Cell type, age group and donor | 3.07e-04 | 167 | 86 | 4 | c4e321bb87512ea839f324c92c0f1afea891483f | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-T_cells-Th17|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.14e-04 | 168 | 86 | 4 | 97bf074b91c9ae0064edc31fa4a2658ffdcfefa3 | |
| ToppCell | droplet-Pancreas-Exocrine-18m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-04 | 169 | 86 | 4 | 53690d6f9712b54aa99a0408aae930d64ae478e5 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.28e-04 | 170 | 86 | 4 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.36e-04 | 171 | 86 | 4 | 1854a777d9eb9d3fc3ed3632332a6f89ce8131da | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.36e-04 | 171 | 86 | 4 | bf475a69db04d4a886e442704955c6a96ff0de46 | |
| ToppCell | droplet-Pancreas-Exocrine|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-04 | 171 | 86 | 4 | 92ac4cc3d54da2ea8e202aa59c78e8875356649e | |
| ToppCell | Nasal_Brush-Epithelial-Ionocytes|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.43e-04 | 172 | 86 | 4 | 04fabb40fa9357d8902f3b04adc15231626cd9f8 | |
| ToppCell | Bronchial_Biopsy-Endothelial-Lymphatic|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.43e-04 | 172 | 86 | 4 | c41f5a66781bbf63afce7ca5d118cc6d8e0fe0bc | |
| ToppCell | Nasal_Brush-Epithelial-Ionocytes|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.43e-04 | 172 | 86 | 4 | dd3a23dc78dc6939f41126f8d7bd23a2e4713647 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Proximal_secretory_2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.51e-04 | 173 | 86 | 4 | d1e47c87bd4750801f3531f66a56c5dccb4ea64c | |
| ToppCell | droplet-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_28|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.51e-04 | 173 | 86 | 4 | 66488d01e03264fb193285470901c9c4182fbae8 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.51e-04 | 173 | 86 | 4 | 464267a2ff3f5c387b6c9c6fa4dab135a221f448 | |
| ToppCell | Endothelial-B-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 3.51e-04 | 173 | 86 | 4 | a81992965137195d20fc498f750975303961a828 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-18m-Endothelial-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-04 | 176 | 86 | 4 | a3f27b5d7edf2d396c085efbe35305cfa0afa565 | |
| ToppCell | droplet-Pancreas-Exocrine-24m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.82e-04 | 177 | 86 | 4 | a5b54792ef948a1e1de66301a60e051250189f59 | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.82e-04 | 177 | 86 | 4 | b1775e05c28883a15c56628028770bc59d3233fb | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.91e-04 | 178 | 86 | 4 | ad3de3e03a401dac64431a541899445262246347 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-Alveolar_Epithelial_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.99e-04 | 179 | 86 | 4 | 88dbec952507d84b85b08165eec80df99ed1e736 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-type_I_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.99e-04 | 179 | 86 | 4 | daf8189a22786171e2b629261cf720736aa4ebdb | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.07e-04 | 180 | 86 | 4 | d67d3196e6cc3dcd31023a4dc69310226181d583 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.07e-04 | 180 | 86 | 4 | 573308d43425d9fba20787abdb7f8efefc48efb5 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.16e-04 | 181 | 86 | 4 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | droplet-Liver-Npc-21m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.25e-04 | 182 | 86 | 4 | dc55de945c6f78f32eb3a1b3520835eb8417e068 | |
| ToppCell | IPF-Myeloid-DC_Langerhans|World / Disease state, Lineage and Cell class | 4.25e-04 | 182 | 86 | 4 | 0e8cfbd8ea196f27a227dbb4d2eb93bc48d27922 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.25e-04 | 182 | 86 | 4 | 215c303df42f13597b2c7a95cb157c6bc7aca9a1 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.25e-04 | 182 | 86 | 4 | 3f1a666fe27dd7529c114539ed5f6b8ca585c875 | |
| ToppCell | droplet-Liver-Npc-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.25e-04 | 182 | 86 | 4 | 010a7364da46101cb5068891fd7bc712ea8f13bd | |
| ToppCell | droplet-Liver-Npc-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.25e-04 | 182 | 86 | 4 | b1ec2015aad1181eac1bbf8d48ad6f2f7ed24a01 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 4.34e-04 | 183 | 86 | 4 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | RSV-Healthy-5|Healthy / Virus stimulation, Condition and Cluster | 4.43e-04 | 184 | 86 | 4 | 1e282d619ef8035437fabe0fd2aefda1c142f7f6 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Neurosecretory-PNEC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.43e-04 | 184 | 86 | 4 | 3e5c68a99c10eb1ddc1048bea4aa9f6b8e2746ff | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 4.43e-04 | 184 | 86 | 4 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | RSV-Healthy-5|RSV / Virus stimulation, Condition and Cluster | 4.43e-04 | 184 | 86 | 4 | ba958f731de6c9eff60103d483e020e2c0c7af7c | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.43e-04 | 184 | 86 | 4 | 1e2f0cec50475a1cf2973a5082826bbc60fc9a68 | |
| ToppCell | COVID-19-Heart-CM_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.43e-04 | 184 | 86 | 4 | e737f0f14c49b07bbb04a165083ac32210bc5690 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.52e-04 | 185 | 86 | 4 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | 3'-Child09-12-SmallIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.52e-04 | 185 | 86 | 4 | 9de1db2ce9e44956b1214daf6e1e161334679c88 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Endothelial-lymphatic_endothelial|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.52e-04 | 185 | 86 | 4 | 18f5d9438c76e37988a7d17aa2a080af6bedbfc4 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.61e-04 | 186 | 86 | 4 | f0b78c7ee20279970ea8961bf59acb5262f2dce5 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.61e-04 | 186 | 86 | 4 | bdc87e4631a8ea73e262e541aa84a28f24c94b00 | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial-parabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.61e-04 | 186 | 86 | 4 | 18c06041c6c8a0ebac17b3c8aaebd67e652d315a | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.61e-04 | 186 | 86 | 4 | 20340a5b5cc7f07386498a4ef937d6fbc9e347c4 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-proliferating_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.61e-04 | 186 | 86 | 4 | a844d4f79e0ad5d6c60a4488ffd8f4f21b7eed04 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.61e-04 | 186 | 86 | 4 | 2b3c814a7dee8286ea113c63dc3de5daf0257d37 | |
| ToppCell | wk_08-11-Epithelial-Distal_epithelial-epi-tip_early|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.70e-04 | 187 | 86 | 4 | 5f9696097741b6e2b7b410c15c6b5ed883ed5eb2 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell|Adult / Lineage, Cell type, age group and donor | 4.70e-04 | 187 | 86 | 4 | 62759efb660179402fb574ce5701c89a2e17bcfe | |
| ToppCell | wk_08-11-Epithelial-Distal_epithelial|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.70e-04 | 187 | 86 | 4 | eefffc2c6f7fa708a96e6bf07c6ce4e6c2e90847 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 4.70e-04 | 187 | 86 | 4 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 4.70e-04 | 187 | 86 | 4 | 78cdcf8bc141d3b155c3c8af908431fc419c4d08 | |
| ToppCell | 15-Distal-Epithelial-Secretory_progenitor|Distal / Age, Tissue, Lineage and Cell class | 4.80e-04 | 188 | 86 | 4 | 9a64fb07de611de38d6f24673feb3b81a5e85384 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.80e-04 | 188 | 86 | 4 | 842982de2197770f999a70083ed9fca40ac22d79 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.80e-04 | 188 | 86 | 4 | c2c51c6526defe2600302901159b8abbb58d7595 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.80e-04 | 188 | 86 | 4 | a0815eaf68eedd6e5ec4af520df80a6ab4eb0864 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 4.90e-04 | 189 | 86 | 4 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | facs-Heart-RA-18m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.90e-04 | 189 | 86 | 4 | 1be5067c1e45af7d09c1fd6955952cb9e031a3a0 | |
| ToppCell | facs-Heart-RA-18m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.90e-04 | 189 | 86 | 4 | 30dc1725d43a60017fb12d706f1f85a33de4947e | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 4.90e-04 | 189 | 86 | 4 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | droplet-Fat-Scat-21m-Endothelial-endothelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.99e-04 | 190 | 86 | 4 | d3e46cf800a07ca9b01c78192962d223b9785d05 | |
| ToppCell | (2)_5-FU-(1)_VE-Cad+_vascular_cells|World / Stress and Cell class | 4.99e-04 | 190 | 86 | 4 | 6b391b8a3ffcbdec3acaf242bc52fc3fc9da77c8 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.99e-04 | 190 | 86 | 4 | 6e6ce6dd549d1c38cfef5b3f8be06ab01ce344b7 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.99e-04 | 190 | 86 | 4 | 4eb92aef1ee868f4537483d19014d947b7684612 | |
| ToppCell | droplet-Fat-Scat-21m-Endothelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.99e-04 | 190 | 86 | 4 | dd89ef1ecea20b2f6fbdc6cea4ca41b28b3ed822 | |
| Drug | formycin triphosphate | 1.25e-06 | 51 | 84 | 5 | CID000122274 | |
| Drug | nocodazole | TAOK2 MYH1 MYH10 AKAP9 MYH13 LZTS1 MYH7B HOOK2 CTNND1 ARHGEF2 GOSR2 | 1.43e-06 | 477 | 84 | 11 | CID000004122 |
| Drug | purealin | 2.38e-06 | 58 | 84 | 5 | CID006419303 | |
| Drug | Mibefradil | 7.82e-06 | 11 | 84 | 3 | DB01388 | |
| Drug | Trazodone hydrochloride [25332-39-2]; Down 200; 9.8uM; HL60; HT_HG-U133A | 8.42e-06 | 197 | 84 | 7 | 2379_DN | |
| Drug | Flurandrenolide [1524-88-5]; Down 200; 9.2uM; HL60; HT_HG-U133A | 8.70e-06 | 198 | 84 | 7 | 2184_DN | |
| Drug | Brompheniramine maleate [980-71-2]; Down 200; 9.2uM; PC3; HT_HG-U133A | 8.99e-06 | 199 | 84 | 7 | 4013_DN | |
| Drug | Acetopromazine maleate salt [3598-37-6]; Up 200; 9uM; HL60; HG-U133A | 9.29e-06 | 200 | 84 | 7 | 1777_UP | |
| Drug | AC1NRBPQ | 1.18e-05 | 137 | 84 | 6 | CID005288569 | |
| Drug | B202 | 1.35e-05 | 2 | 84 | 2 | CID006435965 | |
| Drug | clenbuterol | 1.44e-05 | 142 | 84 | 6 | CID000002783 | |
| Drug | fast white | 1.73e-05 | 42 | 84 | 4 | CID000024008 | |
| Drug | pentasulfane | 2.62e-05 | 16 | 84 | 3 | CID000448216 | |
| Drug | S-(-)-Etomoxir | 3.47e-05 | 100 | 84 | 5 | CID000060765 | |
| Drug | NSC339663 | 3.90e-05 | 250 | 84 | 7 | CID000003892 | |
| Drug | 1,3-dioxoisoindoline-5-carboxamide | 4.03e-05 | 3 | 84 | 2 | CID010679219 | |
| Drug | Phosphatidylinositol 4,5-Diphosphate | 6.14e-05 | 21 | 84 | 3 | ctd:D019269 | |
| Drug | blebbistatin | 7.05e-05 | 116 | 84 | 5 | CID003476986 | |
| Drug | B0683 | 7.34e-05 | 117 | 84 | 5 | CID006398969 | |
| Drug | Prostaglandin E1; Up 200; 10uM; PC3; HT_HG-U133A | 7.39e-05 | 190 | 84 | 6 | 6571_UP | |
| Drug | haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A | 7.61e-05 | 191 | 84 | 6 | 5200_DN | |
| Drug | Econazole nitrate [24169-02-6]; Down 200; 9uM; MCF7; HT_HG-U133A | 7.83e-05 | 192 | 84 | 6 | 7427_DN | |
| Drug | Proguanil hydrochloride [637-32-1]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 7.83e-05 | 192 | 84 | 6 | 3505_DN | |
| Drug | Oxolinic acid [14698-29-4]; Down 200; 15.4uM; HL60; HG-U133A | 7.83e-05 | 192 | 84 | 6 | 1419_DN | |
| Drug | B 207 | 8.03e-05 | 4 | 84 | 2 | CID000063369 | |
| Drug | Tiletamine hydrochloride; Down 200; 15.4uM; MCF7; HT_HG-U133A | 8.29e-05 | 194 | 84 | 6 | 6516_DN | |
| Drug | Clomiphene citrate (Z,E) [50-41-9]; Down 200; 6.6uM; HL60; HT_HG-U133A | 8.53e-05 | 195 | 84 | 6 | 1269_DN | |
| Drug | Spaglumic acid [4910-46-7]; Down 200; 13.2uM; HL60; HT_HG-U133A | 8.53e-05 | 195 | 84 | 6 | 2962_DN | |
| Drug | Sulfaphenazole [526-08-9]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 8.77e-05 | 196 | 84 | 6 | 1673_UP | |
| Drug | Clomipramine hydrochloride [17321-77-6]; Up 200; 11.4uM; HL60; HG-U133A | 8.77e-05 | 196 | 84 | 6 | 1566_UP | |
| Drug | Lisuride (S)(-) [18016-80-3]; Up 200; 11.8uM; HL60; HG-U133A | 8.77e-05 | 196 | 84 | 6 | 2046_UP | |
| Drug | Norfloxacin [70458-96-7]; Down 200; 12.6uM; PC3; HT_HG-U133A | 8.77e-05 | 196 | 84 | 6 | 2090_DN | |
| Drug | Acebutolol hydrochloride [34381-68-5]; Down 200; 10.8uM; PC3; HT_HG-U133A | 8.77e-05 | 196 | 84 | 6 | 6631_DN | |
| Drug | Sulfadimethoxine [122-11-2]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 8.77e-05 | 196 | 84 | 6 | 3441_UP | |
| Drug | Cephalosporanic acid, 7-amino [957-68-6]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 8.77e-05 | 196 | 84 | 6 | 4826_DN | |
| Drug | Riboflavine [83-88-5]; Up 200; 10.6uM; HL60; HG-U133A | 9.02e-05 | 197 | 84 | 6 | 1767_UP | |
| Drug | Desipramine hydrochloride [58-28-6]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 9.02e-05 | 197 | 84 | 6 | 3212_DN | |
| Drug | Praziquantel [55268-74-1]; Down 200; 12.8uM; PC3; HT_HG-U133A | 9.02e-05 | 197 | 84 | 6 | 5874_DN | |
| Drug | Pseudopelletierine hydrochloride [6164-62-1]; Up 200; 21uM; HL60; HG-U133A | 9.02e-05 | 197 | 84 | 6 | 1774_UP | |
| Drug | LY 294002; Down 200; 0.1uM; MCF7; HT_HG-U133A | 9.02e-05 | 197 | 84 | 6 | 5576_DN | |
| Drug | Clofazimine [2030-63-9]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 9.02e-05 | 197 | 84 | 6 | 3239_DN | |
| Drug | Kanamycin A sulfate [25389-94-0]; Down 200; 6.8uM; HL60; HG-U133A | 9.28e-05 | 198 | 84 | 6 | 1609_DN | |
| Drug | PHA-00816795 [212631-79-3]; Up 200; 10uM; PC3; HT_HG-U133A | 9.28e-05 | 198 | 84 | 6 | 7076_UP | |
| Drug | chlorpromazine hydrochloride; Down 200; 1uM; HL60; HT_HG-U133A | 9.28e-05 | 198 | 84 | 6 | 6176_DN | |
| Drug | Metixene hydrochloride [1553-34-0]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 9.28e-05 | 198 | 84 | 6 | 3313_DN | |
| Drug | Pirlindole mesylate [60762-57-4]; Up 200; 12.4uM; HL60; HT_HG-U133A | 9.28e-05 | 198 | 84 | 6 | 3140_UP | |
| Drug | Glutethimide, para-amino [125-84-8]; Down 200; 17.2uM; MCF7; HT_HG-U133A | 9.54e-05 | 199 | 84 | 6 | 7421_DN | |
| Drug | Gallamine triethiodide [65-29-2]; Up 200; 4.4uM; HL60; HG-U133A | 9.54e-05 | 199 | 84 | 6 | 1375_UP | |
| Drug | Metaproterenol sulfate, orciprenaline sulfate [5874-97-5]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 9.54e-05 | 199 | 84 | 6 | 4831_DN | |
| Drug | Scopolamine hydrochloride [55-16-3]; Up 200; 11.8uM; PC3; HT_HG-U133A | 9.54e-05 | 199 | 84 | 6 | 4219_UP | |
| Drug | Flunarizine | 1.34e-04 | 5 | 84 | 2 | DB04841 | |
| Drug | E-130 | 1.34e-04 | 5 | 84 | 2 | CID000072659 | |
| Drug | anacardic acid | 1.83e-04 | 30 | 84 | 3 | CID000167551 | |
| Drug | 3,4-dihydroquinazoline | 2.00e-04 | 6 | 84 | 2 | CID000583065 | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 2.36e-06 | 10 | 81 | 3 | DOID:0110454 (implicated_via_orthology) | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 2.36e-06 | 10 | 81 | 3 | DOID:0111269 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 2.36e-06 | 10 | 81 | 3 | DOID:0080719 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 2.36e-06 | 10 | 81 | 3 | DOID:0111602 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 2.36e-06 | 10 | 81 | 3 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 2.36e-06 | 10 | 81 | 3 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 2.36e-06 | 10 | 81 | 3 | DOID:0080326 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 2.36e-06 | 10 | 81 | 3 | DOID:0111596 (implicated_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 4.31e-06 | 12 | 81 | 3 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 4.31e-06 | 12 | 81 | 3 | DOID:2106 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 5.59e-06 | 13 | 81 | 3 | DOID:397 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 8.85e-06 | 15 | 81 | 3 | DOID:0050646 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 7.11e-05 | 80 | 81 | 4 | DOID:12930 (implicated_via_orthology) | |
| Disease | proline measurement, amino acid measurement | 7.40e-05 | 5 | 81 | 2 | EFO_0005134, EFO_0009773 | |
| Disease | right ventricular ejection fraction measurement | 7.67e-05 | 30 | 81 | 3 | EFO_0021816 | |
| Disease | right ventricular systolic volume measurement | 1.22e-04 | 35 | 81 | 3 | EFO_0021815 | |
| Disease | cryptic phenotype measurement | 2.96e-04 | 47 | 81 | 3 | EFO_0021487 | |
| Disease | myopathy (implicated_via_orthology) | 3.15e-04 | 48 | 81 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | birth weight, pelvic organ prolapse | 3.35e-04 | 49 | 81 | 3 | EFO_0004344, EFO_0004710 | |
| Disease | mean arterial pressure | 4.49e-04 | 499 | 81 | 7 | EFO_0006340 | |
| Disease | Antihypertensive use measurement | 8.27e-04 | 265 | 81 | 5 | EFO_0009927 | |
| Disease | cardiomyopathy (implicated_via_orthology) | 9.96e-04 | 71 | 81 | 3 | DOID:0050700 (implicated_via_orthology) | |
| Disease | hypertrophic cardiomyopathy (is_implicated_in) | 1.66e-03 | 22 | 81 | 2 | DOID:11984 (is_implicated_in) | |
| Disease | cortical thickness change measurement, age at assessment | 1.81e-03 | 23 | 81 | 2 | EFO_0008007, EFO_0021501 | |
| Disease | Brugada Syndrome (disorder) | 1.98e-03 | 24 | 81 | 2 | C1142166 | |
| Disease | proline measurement | 2.32e-03 | 26 | 81 | 2 | EFO_0009773 | |
| Disease | Agents acting on the renin-angiotensin system use measurement | 2.32e-03 | 335 | 81 | 5 | EFO_0009931 | |
| Disease | reticulocyte measurement | 2.37e-03 | 1053 | 81 | 9 | EFO_0010700 | |
| Disease | mean arterial pressure, alcohol drinking | 2.51e-03 | 98 | 81 | 3 | EFO_0004329, EFO_0006340 | |
| Disease | sciatic neuropathy (biomarker_via_orthology) | 2.59e-03 | 99 | 81 | 3 | DOID:11446 (biomarker_via_orthology) | |
| Disease | Hyperplasia | 2.69e-03 | 28 | 81 | 2 | C0020507 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EDEENREHRVRRIHV | 296 | Q8WZ19 | |
| EAERRRQHDEAARRL | 1661 | P55196 | |
| SQRREERISDNRDHI | 41 | P0CW23 | |
| ADERTQAAERLRHDA | 611 | Q86VI1 | |
| QEELRERLHEESRAR | 1896 | Q99996 | |
| EHRLSRQDLEAREDA | 231 | Q8WWN8 | |
| QARRAEAEAHREAEA | 771 | A6NC98 | |
| SEGRQHLEEAERERR | 851 | A6NC98 | |
| NEAEEERLRGEREHQ | 181 | Q7L8J4 | |
| EDALEQARRAHEEAR | 1266 | O60885 | |
| QARRAHEEARRRQEQ | 1271 | O60885 | |
| RSVHRNFEDRERQEL | 916 | Q92974 | |
| EEIAQRRERARQRHA | 436 | Q7Z2Z2 | |
| HQRDREPEREERKEE | 276 | Q9H201 | |
| RELEAVEHRIREEQR | 121 | Q14129 | |
| RAAEERHQAGRREVE | 101 | A6NFT4 | |
| DREAVRREAERQAQA | 91 | Q08289 | |
| RHRSRDVDREQDHNE | 606 | Q08289 | |
| QRRRREEEERQRHAE | 901 | Q9HCE9 | |
| KAREEHERAQREEEA | 256 | P50502 | |
| HERAQREEEARRQSG | 261 | P50502 | |
| ALRARNEHRQADELE | 441 | P15918 | |
| EEDRRRRRVDFHDVQ | 126 | Q969Q5 | |
| DRQRDELRAHNRDLR | 121 | Q96NA2 | |
| QRERELSQRDEHVQE | 611 | Q9BXF6 | |
| ERALETRHEQEQRRL | 991 | Q6P2E9 | |
| REEDQRGLRERHRLQ | 26 | A1A4G5 | |
| NRISEDVEERLARHR | 91 | P55081 | |
| RLRAELREERQGHDQ | 506 | Q9Y250 | |
| ERHREERRRQQQLDA | 151 | Q9NWZ8 | |
| HAERTRQLEDELRRA | 341 | Q96ED9 | |
| AADRERQEELQRHLE | 476 | Q96ED9 | |
| DDRVERVRRAHLNDL | 66 | P10620 | |
| ARARAHARDQAREQD | 336 | Q13585 | |
| QEELERERVELQRHR | 2391 | Q9UPA5 | |
| RERVELQRHREEEQL | 2396 | Q9UPA5 | |
| KREERIEEQQHRNRE | 271 | Q5CZC0 | |
| RHLERALEERRRQEE | 1496 | A7E2Y1 | |
| HLLEAERQERARAEA | 81 | Q9UHG2 | |
| RARRDHFSIERAQQE | 101 | Q9NUL7 | |
| EARLRHEVQDARDQN | 591 | Q5VZ66 | |
| REQEDRLHEQEERLR | 216 | A6NEF3 | |
| RLHEQEERLREQEER | 221 | A6NEF3 | |
| RQEERLREQEERLHE | 196 | A6NI86 | |
| RQEERLREQEERLHE | 196 | H0YKK7 | |
| RHAREQQERQREELL | 91 | O14653 | |
| RRIQHELEEAEERAD | 1901 | P12882 | |
| RERRYREREQQIEEH | 221 | Q16643 | |
| EAERKLEEQQRRHRE | 201 | Q02818 | |
| RENLEDEYEPRRRDH | 86 | P49643 | |
| REAQVDAEAQRRLEH | 1046 | Q01970 | |
| EDIAHVRQRLDDEAR | 176 | P12036 | |
| ERAHRQRVRGLEEQV | 1976 | Q5TZA2 | |
| HDIERRRKERLQNED | 556 | A2AJT9 | |
| HQEEEEARRREEKRL | 1546 | O43497 | |
| AERERELEECQRNHE | 171 | Q9UNE7 | |
| LEQALRRRESEHERE | 196 | Q8N4Y2 | |
| HQESLAAERERRRQE | 451 | Q2V2M9 | |
| EKRDEQRRRHQDELD | 716 | Q96GE4 | |
| RELEAVEHRIREEQR | 121 | Q9BY27 | |
| DRERLHRELRSEEEN | 331 | Q8TDC3 | |
| EREERLQQENHELRR | 91 | A1A5D9 | |
| EEERRRSQHRELQQA | 381 | Q9H4E7 | |
| REEEERLRNKIRADH | 101 | O60476 | |
| EHLVEQRTRELRERA | 546 | Q9NQR7 | |
| ERHRAEVRRAVNDER | 61 | Q7Z589 | |
| LEQQRQEQEVERHRR | 106 | Q9UKV0 | |
| CRQHQEAEEARRREE | 1561 | O95180 | |
| EEERRHVSAQLERVR | 31 | O60716 | |
| RARRHAEQERDELAD | 1701 | P35580 | |
| RSRNHRTGDQEERQD | 166 | Q15773 | |
| QRERRRVLEENHVEH | 836 | Q9H4L5 | |
| EVQRIRHEFRDDLDE | 816 | Q9HB75 | |
| ARQRDHEKQQERVRE | 511 | Q16363 | |
| QELRNEEENTHPRER | 336 | P07332 | |
| DNRERQEHNDRRSLG | 31 | P49768 | |
| EERRHAEAKDQLERA | 441 | A5D8V7 | |
| EREEHSARLQRELEA | 516 | Q9UL54 | |
| EQARRRLDAQREEHE | 1271 | Q9Y2I6 | |
| ADRDRIDEARQELHR | 91 | P62330 | |
| RADEDCVDDRARHRE | 721 | O15417 | |
| ERAEVQRLEEQERRH | 356 | Q86UC2 | |
| QRLEEQERRHREEKE | 361 | Q86UC2 | |
| DSEDSERRRNHNILE | 376 | P04198 | |
| RRVQHELEEAAERAD | 1901 | Q9UKX3 | |
| EREQREREQRLEAFH | 641 | Q14151 | |
| EQERIHREREELRRQ | 701 | Q14151 | |
| HRLSEEERRRQQQEE | 176 | Q9BW85 | |
| EARRRQHEAEEGVRR | 2691 | Q15149 | |
| EDDLLEYHRRQRQER | 586 | Q86UU1 | |
| PRDERRRAQHNEVER | 231 | Q15853 | |
| EEELHRQERLRNHER | 46 | Q9HBF4 | |
| EEDESELELSHNRRR | 1286 | Q9ULL1 | |
| REQQLRREQEEERHE | 421 | Q07283 | |
| EERAHRQQQEEEQRR | 751 | Q07283 | |
| QEREEQQLHRQERDR | 1471 | Q07283 | |
| HGERDRRDNRERDQR | 626 | Q5T200 | |
| RHQGRNDELERDERR | 646 | Q5T200 | |
| EIREDRNPRDGHDER | 806 | Q5T200 | |
| RDRLQERDRYEHDRE | 1296 | Q5T200 |